Annals ofMultiple Sclerosis
Volume: 3 - Number: 19 - August 15, 2006
Outstanding
Premyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis
Medical Progress: Multiple Sclerosis — The Plaque and Its Pathogenesis
Clinical Implications of Basic Research
An Array of Sunshine in Multiple Sclerosis
Molecular Mimicry in Multiple Sclerosis
Editorial
Selective Treatment of Multiple Sclerosis
The Lesions of Multiple Sclerosis
Original Articles
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Brief Report:Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab
Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy
Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis
Premyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis
Perspective
Do Myelin-Directed Antibodies Predict Multiple Sclerosis?
Reviews
Current Concepts: Primary Progressive Aphasia — A Language-Based Dementia
Mechanisms of Disease: Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Mechanisms of Disease: Calpains and Disease
Medical Progress: Multiple Sclerosis — The Plaque and Its Pathogenesis
